136,115 research outputs found

    Helminth Infections: Recognition and Modulation of the Immune Response by Innate Immune Cells

    Get PDF
    The survival of helminths in the host over long periods of time is the result of a process of adaptation or dynamic co-evolution between the host and the parasite. However, infection with helminth parasites causes damage to the host tissues producing the release of danger signals that induce the recruitment of various cells, including innate immune cells such as macrophages (Mo), dendritic cells (DCs), eosinophils, basophils, and mast cells. In this scenario, these cells are able to secrete soluble factors, which orchestrate immune effector mechanisms that depend on the different niches these parasites inhabit. Here, we focus on recent advances in the knowledge of excretory-secretory products (ESP), resulting from helminth recognition by DCs and Mo. Phagocytes and other cells types such as innate lymphocyte T cells 2 (ILC2), when activated by ESP, participate in an intricate cytokine network to generate innate and adaptive Th2 responses. In this review, we also discuss the mechanisms of innate immune cell-induced parasite killing and the tissue repair necessary to assure helminth survival over long periods of time.Fil: Motran, Claudia Cristina. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Silvane, Leonardo Micael. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Chiapello, Laura Silvina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; Argentina. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; ArgentinaFil: Theumer, MartĂ­n Gustavo. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Ambrosio, Laura Fernanda. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Volpini, Ximena. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; Argentina. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; ArgentinaFil: Celias, Daiana Pamela. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; Argentina. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; ArgentinaFil: Cervi, Laura Alejandra. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; Argentin

    Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients

    Get PDF
    AIM: To evaluate novel risk factors and biomarkers of cardiovascular disease in celiac disease (CD) patients compared with healthy controls.METHODS:Twenty adult patients with recent diagnosis of CD and 20 sex, age and body mass index-matched healthy controls were recruited during a period of 12 mo.Indicators of carbohydrate metabolism, hematological parameters and high sensitive C reactive protein were determined. Moreover, lipoprotein metabolism was also explored through evaluation of the lipid profile and the activity of cholesteryl ester transfer protein and lipoprotein associated phospholipase A2, which is also considered a specific marker of vascular inflammation. The protocol was approved by the Ethic Committee from School of Pharmacy and Biochemistry, University of Buenos Aires and from Buenos Aires Italian Hospital, Buenos Aires, Argentina.RESULTS: Regarding the indicators of insulin resistance, CD patients showed higher plasma insulin levels [7.2 (5.0-11.3) mU/L vs 4.6 (2.6-6.7) mU/L, P < 0.05], increased Homeostasis Model Assessment-Insulin Resistance [1.45 (1.04-2.24) vs 1.00 (0.51-1.45), P < 0.05] and lower Quantitative Sensitive Check index [0.33 (0.28-0.40) vs 0.42 (0.34-0.65), P < 0.05] indexes. Folic acid concentration [5.4 (4.4-7.9) ng/mL vs 12.2 (8.0-14.2) ng/mL, P < 0.01] resulted to be lower and High-sensitivity C reactive protein levels higher (4.21 ± 6.47 mg/L vs 0.98 ± 1.13 mg/L, P < 0.01) in the patient group. With respect to the lipoprotein profile, CD patients showed lower high density lipoproteincholesterol (HDL-C) (45 ± 15 mg/dL vs 57 ± 17 mg/dL, P < 0.05) and apo A-I (130 ± 31 mg/dL vs 155 ± 29 mg/ dL, P < 0.05) levels, as well as higher total cholesterol/ HDL-C [4.19 (3.11-5.00) vs 3.52 (2.84-4.08), P < 0.05] and apo B/apo A-I (0.75 ± 0.25 vs 0.55 ± 0.16, P < 0.05) ratios in comparison with control subjects. No statistically significant differences were detectedin lipoprotein-associated lipid transfer protein and enzymes.CONCLUSION: The presence and interaction of the detected alterations in patients with CD, would constitute a risk factor for the development of atherosclerotic cardiovascular disease.Fil: Tetzlaff, Walter Francisco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Meroño, Tomås. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Menafra, Martín. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Martin, Maximiliano. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Botta, Eliana Elizabeth. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Matoso, María Dolores. Hospital Italiano; ArgentinaFil: Sorroche, Patricia Beatriz. Hospital Italiano; ArgentinaFil: De Paula, Juan A. Hospital Italiano; ArgentinaFil: Boero, Laura Estela. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Brites, Fernando Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentin

    Antagonistic and Synergistic Activation of Cardiovascular Vagal and Sympathetic Motor Outflows in Trigeminal Reflexes

    Get PDF
    The trigeminal nerve and heart are strongly related through somato-autonomic nervous reflexes that induce rapid changes in cardiovascular function. Several trigeminal reflexes have been described, but the diving and trigeminocardiac reflexes are the most studied. The heart is a target organ dually innervated by the sympathetic and parasympathetic systems. Thus, how cardiac function is regulated during the trigeminal reflexes is the result of the combination of an increased parasympathetic response and increased, decreased, or unaltered sympathetic activity. Various hemodynamic changes occur as a consequence of these alterations in autonomic tone. Often in the oxygen-conserving physiological reflexes such as the diving reflex, sympathetic/parasympathetic co-activation reduces the heart rate and either maintains or increases blood pressure. Conversely, in the trigeminocardiac reflex, bradycardia and hypotension due to parasympathetic activation and sympathetic inactivation tend to be observed. These sudden cardiac innervation disturbances may promote the generation of arrhythmias or myocardial ischemia during surgeries in the trigeminal territory. However, the function and mechanisms involved in the trigeminal reflexes remain to be fully elucidated. The current review provides a brief update and analysis of the features of these reflexes, with special focus on how the autonomic nervous system interacts with cardiovascular function.Fil: Buchholz, Bruno. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de BioquĂ­mica y Medicina Molecular. Instituto de BioquĂ­mica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de PatologĂ­a; ArgentinaFil: Kelly, JazmĂ­n. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de BioquĂ­mica y Medicina Molecular. Instituto de BioquĂ­mica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de PatologĂ­a; ArgentinaFil: Bernatene, Eduardo Alberto. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de BioquĂ­mica y Medicina Molecular. Instituto de BioquĂ­mica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de PatologĂ­a; ArgentinaFil: MĂ©ndez Diodati, Nahuel. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de BioquĂ­mica y Medicina Molecular. Instituto de BioquĂ­mica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de PatologĂ­a; ArgentinaFil: Gelpi, Ricardo Jorge. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de BioquĂ­mica y Medicina Molecular. Instituto de BioquĂ­mica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de PatologĂ­a; Argentin

    Synthesis, anti-tuberculosis activity and QSAR study of 2,4-diarylquinolines and analogous polycyclic derivatives

    Get PDF
    The multicomponent syntheses of 2,4-di-aryl-quinolines and analogous polycyclic derivatives as anti-tuberculosis agents were described. They were prepared via Beyer and FriedlĂ€nder methods under microwave irradiation in short reaction times and good yields. Several homogeneous and heterogeneous acid catalysts were compared for preparing 2,4-di-arylquinolines and among them trifluoroacetic acid (TFA) reached the higher yields. Two derivatives exhibited activity against Mycobacterium tuberculosis H37Rv (Mtb), underwent additional testing and were considered lead compounds. The synthesis of a series of polycyclic analogous led to six new active compounds and a Quantitative Structure Activity Relationship study (QSAR) study was established.Fil: Muscia, Gisela Celeste. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay; ArgentinaFil: Carnevale, Juan Pablo. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; ArgentinaFil: Luczywo, Ayelen. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; ArgentinaFil: Victoria PelĂĄez, MarĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; ArgentinaFil: RodrĂ­guez Ó Toole, Ailen. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; ArgentinaFil: Buldain, Graciela Yolanda. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; ArgentinaFil: Casal, Juan JosĂ©. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay; ArgentinaFil: AsĂ­s, Silvia Elizabeth. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de QuĂ­mica OrgĂĄnica; Argentin

    FABP-2 and PPAR-Îł Haplotype as Risk Factors for Dyslipidemia in a Type 2 Diabetes Mellitus Population of Santa Rosa del Conlara, San Luis, Argentina

    Get PDF
    Introduction: Type 2 Diabetes Mellitus (T2DM) is a complex disorder caused by the interaction between genetic predisposition and environmental factors. Genetics plays an important role on lipid homeostasis. Many genes are involved in the lipid metabolism, such as FABP-2 and PPAR-Îł. Aim: To evaluate the association between specific SNPs and haplotypes of the FABP-2 and PPAR-Îł genes with T2DM and lipid profile in an Argentinean population. Methods: The FABP-2 (rs1799883) and PPAR-Îł (rs1801282) polymorphisms were genotyped and analyzed in association with lipid profile and T2DM, separately and also combined in haplotypes. Results: The frequency of the rare Thr54 allele of the FABP-2 polymorphism in control (0.33) was not different from the frequency in T2DM (0.27), whereas the frequency of the rare Ala12 allele of the PPAR-Îł polymorphism in control was different from the frequency in T2DM (0.26 and 0.14, respectively; p = 0.0031). Frequencies of haplotypes for these two single-nucleotide polymorphisms differed significantly in control and T2DM. Haplotype association analysis showed the associations between ThrPro haplotype and TG levels (OR = 2.520; 95% CI = 1.139 - 5.575; p = 0.027) and between ThrPro haplotype and TC and LDL-c levels when compared to AlaPro haplotype (difference = 0.175, 95% CI = 0068 - 0.499, p < 0.0001; difference = 0.052, 95% CI = 0.017 - 0.158, p < 0.0001, respectively). Conclusions: These results from a haplotype analysis show for the first time that genetic combinations of alleles of the FABP-2 and PPAR-Îł gene could play a role in the susceptibility to develop dyslipemia in T2DM.Fil: Siewert, Susana Elfrida. Universidad Nacional de San Luis. Facultad de QuĂ­mica, BioquĂ­mica y Farmacia. Departamento de BioquĂ­mica y Ciencias BiolĂłgicas. Laboratorio de Diabetes; ArgentinaFil: Olmos Nicotra, Maria Florencia. Universidad Nacional de San Luis. Facultad de QuĂ­mica, BioquĂ­mica y Farmacia. Departamento de BioquĂ­mica y Ciencias BiolĂłgicas. Laboratorio de Diabetes; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas; ArgentinaFil: Gonzalez, Irma Ines. Universidad Nacional de San Luis. Facultad de QuĂ­mica, BioquĂ­mica y Farmacia. Departamento de BioquĂ­mica y Ciencias BiolĂłgicas. Laboratorio de Diabetes; ArgentinaFil: Fernandez, Gustavo. Universidad Nacional de San Luis. Facultad de QuĂ­mica, BioquĂ­mica y Farmacia. Departamento de BioquĂ­mica y Ciencias BiolĂłgicas. Laboratorio de Diabetes; ArgentinaFil: Ojeda, Marta Susana. Universidad Nacional de San Luis. Facultad de QuĂ­mica, BioquĂ­mica y Farmacia. Departamento de BioquĂ­mica y Ciencias BiolĂłgicas. Laboratorio de Diabetes; Argentin

    Ketamine effect on intracellular and mitochondrial calcium mobilization

    Get PDF
    The suppressive effects of ketamine on intracellular calcium has been reported in a variety of cells although the mechanisms involved are not well understood. The aim of this work was to evaluate the ketamine effect on the mitochondrial Ca2+  accumulation and the cellular Ca  mobilization using FLUO4-AM and flow cytometry. The results showed that mitochondria from ketamine injected animals presented a lower ability to retain calcium at concentrations higher than 20 ÎŒM, as compared with controls (saline injected animals). In addition, ketamine showed a significant decreased KCl-induced intracellular calcium concentration. KCl increased calcium influx through cellular depolarization. According to the data presented herein, ketamine presents a clear inhibitory effect on cytosolic Ca2+  transport mechanisms, independently from their action on the calcium channel associated NMDA receptor.Fil: Bustamante, Jaunita. Universidad Abierta Interamericana. Facultad de Medicina. Centro de Altos Estudios en Ciencias de la Salud; ArgentinaFil: Czerniczyniec, Analia. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de BioquĂ­mica y Medicina Molecular; ArgentinaFil: Lores Arnaiz, Silvia. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de BioquĂ­mica y Medicina Molecular. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de BioquĂ­mica y Medicina Molecular; Argentin

    A Validated Reversed-Phase HPLC Method for the Determination of Atorvastatin Calcium in Tablets

    Get PDF
    A Reversed-Phase Liquid Chromatographic (RP-LC) assay method was developed for the quantitative determination of atorvastatin calcium in the presence of its degradation products. The assay involved an isocratic elution of atorvastatin calcium in a LiChroCARTR 250*4 mm HPLC Cartridge LiChrospherR 100 RP-18 (5 ÎŒm) column using a mobile phase consisting of 0.1% acetic acid solution: acetonitrile (45:55, v/v), pH = 3.8. The flow rate was 0.8 mL/min and the analytes monitored at 246 nm. The assay method was found to be linear from 8.13 to 23.77 ÎŒg/mL. All the validation parameters were within the acceptance range. The developed method was successfully applied to estimate the amount of atorvastatin calcium in tablets.Fil: Simionato, Laura Daniela. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de TecnologĂ­a FarmacĂ©utica; ArgentinaFil: Ferello, L.. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de TecnologĂ­a FarmacĂ©utica; ArgentinaFil: Stamer. S.. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de TecnologĂ­a FarmacĂ©utica; ArgentinaFil: Repetto, M. F.. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de TecnologĂ­a FarmacĂ©utica; ArgentinaFil: Zubata, P. D.. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de TecnologĂ­a FarmacĂ©utica; ArgentinaFil: Segall, Adriana Ines. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de TecnologĂ­a FarmacĂ©utica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay; Argentin

    La captaciĂłn de colesterol por Tetrahymena thermophila se realiza principalmente por fagocitosis

    Get PDF
    The free-living ciliate Tetrahymena thermophila is a unicellular model organism in which landmark biological processes have been discovered, such as the first description of telomerase activity and the molecular structure of telomeres, the mechanism of self-splicing RNA and ribozymes, the function of histone acetylation in transcription regulation and a number of pioneer experiments on the interference (RNAi) mechanism for programmed genome rearrangements, among others...Fil: Elguero, MarĂ­a Eugenia. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de NanobiotecnologĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de NanobiotecnologĂ­a; ArgentinaFil: SĂĄnchez Granel, MarĂ­a Luz. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de NanobiotecnologĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de NanobiotecnologĂ­a; ArgentinaFil: Montes, MarĂ­a Guadalupe. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de NanobiotecnologĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de NanobiotecnologĂ­a; ArgentinaFil: Cid, NicolĂĄs Gonzalo. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de NanobiotecnologĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de NanobiotecnologĂ­a; ArgentinaFil: Favale, Nicolas Octavio. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de QuĂ­mica y FĂ­sico-QuĂ­mica BiolĂłgicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de QuĂ­mica y FĂ­sico-QuĂ­mica BiolĂłgicas; ArgentinaFil: Nudel, Berta Clara. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de NanobiotecnologĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de NanobiotecnologĂ­a; ArgentinaFil: Nusblat, Alejandro David. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de NanobiotecnologĂ­a. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de NanobiotecnologĂ­a; Argentin

    Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus

    Get PDF
    Background: In the present work we described the recombinant production and characterization of heterodimeric construction ZnT8-Arg-Trp325 fused to thioredoxin using a high-performance expression system such as Escherichia coli. In addition, we apply this novel recombinant antigen in a non-radiometric method, with high sensitivity, low operational complexity and lower costs. Results: ZnT8 was expressed in E. coli as a fusion protein with thioredoxin (TrxZnT8). After 3 h for induction, recombinant protein was obtained from the intracellular soluble fraction and from inclusion bodies and purified by affinity chromatography. The expression and purification steps, analyzed by SDS-PAGE and western blot, revealed a band compatible with TrxZnT8 expected theoretical molecular weight (≈ 36.8 kDa). The immunochemical ability of TrxZnT8 to compete with [35S]ZnT8 (synthesized with rabbit reticulocyte lysate system) was assessed qualitatively by incubating ZnT8A positive patient sera in the presence of 0.2-0.3 ÎŒM TrxZnT8. Results were expressed as standard deviation scores (SDs). All sera became virtually negative under antigen excess (19.26-1.29 for TrxZnT8). Also, radiometric quantitative competition assays with ZnT8A positive patient sera were performed by adding TrxZnT8 (37.0 pM-2.2 ÎŒM), using [35S]ZnT8. All dose-response curves showed similar protein concentration that caused 50% inhibition (14.9-0.15 nM for TrxZnT8). On the other hand, preincubated bridge ELISA for ZnT8A detection was developed. This assay showed 51.7% of sensitivity and 97.1% of specificity. Conclusions: It was possible to obtain with high-yield purified heterodimeric construction of ZnT8 in E. coli and it was applied in cost-effective immunoassay for ZnT8A detection.Fil: Faccinetti, Natalia Ines. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Guerra, Luciano Lucas. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Sabljic, Adriana Victoria. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Bombicino, Silvina Sonia. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Rovitto, Bruno David. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Iacono, Ruben Francisco. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Poskus, Edgardo. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Trabucchi, Aldana. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; ArgentinaFil: Valdez, Silvina Noemi. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y BioquĂ­mica. Departamento de MicrobiologĂ­a, InmunologĂ­a y BiotecnologĂ­a; Argentin

    S-nitrosylation of NF-kB p65 inhibits TSH-induced Na+/I- symporter expression

    Get PDF
    Nitric oxide (NO) is a ubiquitous signaling molecule involved in a wide variety of cellular physiological processes. In thyroid cells, NO-synthase III-endogenously produced NO reduces thyrotropin (TSH)-stimulated thyroid specific gene expression, suggesting a potential autocrine role of NO in modulating thyroid function. Further studies indicate that NO induces thyroid dedifferentiation, as NO donors repress TSH-stimulated I- uptake. Here, we investigated the molecular mechanism underlying the NO inhibited Na+/I- Symporter (NIS)-mediated I- uptake in thyroid cells. We showed that NO donors reduce I- uptake in a concentration-dependent manner, which correlates with decreased NIS protein expression. NO-reduced I- uptake results from transcriptional repression of NIS gene rather than post-translational modifications reducing functional NIS expression at the plasma membrane. We observed that NO donors repress TSH-induced NIS gene expression by reducing the transcriptional activity of the NF-ÎșB subunit p65. NO-promoted p65 S-nitrosylation reduces p65-mediated transactivation of the NIS promoter in response to TSH stimulation. Overall, our data are consistent with the notion that NO plays a role as an inhibitory signal to counterbalance TSH-stimulated NF-ÎșB activation, thus modulating thyroid hormone biosynthesis.Fil: Nicola, Juan Pablo. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Peyret, Victoria. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Nazar, MagalĂ­. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentina. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Romero, Jorge Miguel. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - CĂłrdoba. Centro de Investigaciones en QuĂ­mica BiolĂłgica de CĂłrdoba. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Centro de Investigaciones en QuĂ­mica BiolĂłgica de CĂłrdoba; ArgentinaFil: Lucero, Ariel Maximiliano. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Montesinos, Maria del Mar. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Bocco, Jose Luis. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Pellizas, Claudia Gabriela. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico CĂłrdoba. Centro de Investigaciones en BioquĂ­mica ClĂ­nica e InmunologĂ­a; ArgentinaFil: Masini, Ana MarĂ­a. Universidad Nacional de CĂłrdoba. Facultad de Ciencias QuĂ­micas. Departamento de BioquĂ­mica ClĂ­nica; Argentin
    • 

    corecore